![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1383495
ÀÇ·á±â±â ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Medical Device Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°è ÀÇ·á±â±â ½ÃÀåÀº 2023³â 5,526¾ï ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È 7.9%ÀÇ CAGR·Î 2030³â 9,410¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áúº´À̳ª ¼Õ»óÀ» ½Äº°, ¿ÏÈ, ¸ð´ÏÅ͸µ, Ä¡·á, ¿¹¹æÇÏ´Â µ¥ »ç¿ëÇϵµ·Ï ¼³°èµÈ ±â±â, ±â°è, ÀÓÇöõÆ®, ü¿Ü ½Ã¾à µîÀ» ÀÇ·á±â±â¶ó°í ÇÕ´Ï´Ù. ÀÇ·á±â±â´Â ´Ù¾çÇÑ ¿ëµµ¿Í ³ôÀº ¼öÁØÀ» °¡Áö°í ÀÖÁö¸¸, ÀÇ·á Àå¾Ö¸¦ Áø´ÜÇϰí Ä¡·áÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ¸ðµÎ °Ç° °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. Á¦Á¶¾÷ü, ¼Ò¸Å¾÷ü ¹× ±ÔÁ¦ ±â°üÀº ¸ðµÎ ¼¼°è ºñÁö´Ï½ºÀÎ ÀÇ·á±â±â ºÐ¾ß¿¡¼ ±¹Á¦ÀûÀ¸·Î Ȱµ¿Çϰí ÀÖ½À´Ï´Ù.
IDF°¡ ¹ßÇ¥ÇÑ 2022³â Åë°è¿¡ µû¸£¸é 2021³â ij³ª´Ù¿¡¼ ¾à 290¸¸ ¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ ¼öÄ¡´Â 2030³â¿¡´Â 320¸¸ ¸í, 2045³â¿¡´Â 340¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
ÀÇ·á±â±â ½ÃÀåÀº ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀº ´ç´¢º´, È£Èí±â Áúȯ, ½ÉÇ÷°ü Áúȯ, ÀϺΠ¾Ï µî Áö¼ÓÀûÀÎ °ü¸®¿Í °üÂûÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, »ó½Ã ¸ð´ÏÅ͸µÀÇ Çʿ伺À¸·Î ÀÎÇØ ȯÀÚ ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀº ±â¼úÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼ ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â ºí·çÅõ½º, ÀÎÅÍ³Ý Á¢¼Ó µî ¿¬°á¼ºÀ» °®Ãá ÀÇ·á±â±â¸¦ ÅëÇØ ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù.
°í°¡ÀÇ ÀÇ·á Àåºñ´Â ƯÈ÷ °ø°ø ÀÚ±ÝÀ» Áö¿ø¹Þ´Â ½Ã½ºÅÛ¿¡¼ ÀÇ·á ÀçÁ¤À» ¾Ð¹ÚÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿ø ¹× ±âŸ ÀÇ·á±â°üÀÇ °æ¿ì, ÷´Ü ±â¼úÀ» ±¸ÀÔÇϰí À¯ÁöÇÏ´Â µ¥ µå´Â ºñ¿ëÀÌ ¾öû³ª°Ô ³ô¾Æ Àüü ¿î¿µ ¿¹»ê¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ ¿Ü·¡ Áø·á¼Ò³ª Áö¹æ Áø·á¼Ò¿Í °°Àº ¼Ò±Ô¸ð ÀÇ·á ±â°üÀº °í°¡ÀÇ ÀÇ·á±â±â¸¦ ±¸ÀÔÇϱ⠾î·Á¿ö ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇϱⰡ ¾î·Á¿öÁ® ÀÇ·á ¼ºñ½º Á¦°ø¿¡ °ÝÂ÷°¡ ¹ß»ýÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ç÷´ç ÃøÁ¤±â, ¿þ¾î·¯ºí ÇÇÆ®´Ï½º Æ®·¡Ä¿, Ç÷¾Ð ¸ð´ÏÅÍ¿Í °°Àº °¡Á¤¿ë ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ±â±â¸¦ ÅëÇØ »ç¶÷µéÀº ÀÇ·á±â°üÀ» ¹æ¹®ÇÏÁö ¾Ê°íµµ ÀÚ½ÅÀÇ °Ç° ¹®Á¦¸¦ ÆÄ¾ÇÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ °¡Á¤¿ë ÀÇ·á±â±âÀÇ ¼ö¿ä·Î ÀÎÇØ ±â¼úÀº Áö¼ÓÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀÇ Àü¹ÝÀûÀÎ °æÇèÀ» °³¼±Çϱâ À§ÇØ Á¦Á¶¾÷üµéÀº Á÷°üÀûÀÎ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º, ¿¬°á ±â´É, ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ±â±â¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. °¡Á¤¿ë µðÁöÅРü¿Â°è¿Í ¿ø°Ý ÀÇ·á Ç÷§ÆûÀº ¿ø°Ý Áø·á°¡ °¡´ÉÇÑ ±â±âÀÇ ´ëÇ¥ÀûÀÎ ¿¹À̸ç, ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
±ÔÁ¦ Á¶Á¤À¸·Î ÀÎÇØ ȯÀÚ ¼ºñ½º Á¦°ø ¹× ½ÅÁ¦Ç° °³¹ß ºñ¿ëÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒºñÀÇ ºñ¹Ð°ú °ü·ÃµÈ ¹ßÀü¿¡´Â À¯·´¿¬ÇÕ(EU)ÀÌ ½ÃÇàÇÑ ÀÏ¹Ý µ¥ÀÌÅÍ º¸È£ ±ÔÁ¤(GDPR)°ú ±â±â ½ÂÀÎ ¼öÁ¤ÀÌ Æ÷ÇԵ˴ϴÙ. ¹Ì±¹ FDA´Â ³»½Ã°æ µµ±¸¿Í °°Àº ÀÇ·á±â±âÀÇ ¾ÈÀü¼º ¹× À¯È¿¼º ÁÖÀåÀ» µÞ¹ÞħÇϱâ À§ÇØ ´õ ¸¹Àº ÀÓ»ó Áõ°Å¸¦ ¿ä±¸Çϰí ÀÖÀ¸¸ç, ±× °á°ú Áö³ 10³â°£ ÆÇ¸Å ½ÂÀÎ ÀýÂ÷¸¦ ¿Ï·áÇÏ´Â µ¥ ÇÊ¿äÇÑ ½Ã°£ ¿¬ÀåÀÌ °¨¼ÒÇß½À´Ï´Ù. ±â±â Ãâ½Ã Áö¿¬À¸·Î ÀÎÇÑ ¼öÀÍ ¼Õ½Ç°ú ±î´Ù·Î¿î ±ÔÁ¦ ÀýÂ÷·Î ÀÎÇÑ ºñ¿ë »ó½Â °¡´É¼ºÀº Çõ½ÅÀûÀÎ ±â±â¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¾Ð¹ÚÇϰí ÀÇ·á±â±â ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
COVID-19ÀÇ ´ëÀ¯ÇàÀº Àü ¼¼°è ÀÇ·á±â±â ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Äڷγª ¹ÙÀÌ·¯½º Áø´ÜÀÌ ¿¹»óÄ¡ ¸øÇÏ°Ô Áõ°¡ÇÔ¿¡ µû¶ó È£Èí±â, ÀΰøÈ£Èí±â, ¸¶½ºÅ©, °³Àκ¸È£±¸ ŰƮ µî ÀÇ·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú °°Àº µðÁöÅÐ °Ç° ±â¼úÀÇ »ç¿ëÀº COVID-19 À¯Çà ±â°£ µ¿¾È ±Þ°ÝÈ÷ Áõ°¡Çß½À´Ï´Ù. ÀÇ·á±â±â ½ÃÀåÀº Áö±Ý ´õ ºü¸¥ ¼Óµµ·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª COVID-19°¡ ÀýÁ¤¿¡ ´ÞÇßÀ» ¶§ ºÒÇÊ¿äÇÑ ¼ö¼úÀº ¸ðµÎ º¸·ùµÇ°í ¼±ÅÃÀû ¼ö¼ú Ä¡·á°¡ ¿ì¼±¼øÀ§¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ÇÊ¿äÇÑ ¼ö¼ú¿¡ ÇÊ¿äÇÑ ÀÇ·á±â±â¸¦ Á¦Á¶ÇÏ´Â ±â¾÷¿¡ ¾Ç¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.
½ÉÀ庴ÇÐ ±â±â ºÐ¾ß´Â ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Àú¸íÇÑ ¾÷°è ±â¾÷ÀÇ Àü¼úÀû ¿òÁ÷ÀÓ, ½ÉÀ庴ÇÐ ±â±âÀÇ ±â¼ú ¹ßÀü µî ¿©·¯ °¡Áö ÀÌÀ¯·Î ÀÎÇØ À¯¸®ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ, ºñ¸¸, ´ç´¢º´, °íÇ÷¾Ð, °íÄÝ·¹½ºÅ×·ÑÀ» °¡Áø »ç¶÷µéÀÌ ´õ ¿À·¡ »ì¸é¼ ½ÉÀå ÁúȯÀ» °æÇèÇϱ⠽±±â ¶§¹®¿¡ ÀÌ·¯ÇÑ Áúº´µµ ½ÉÀ庴 ÀÇ·á±â±âÀÇ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ç¾÷ È®Àå ¹× ±â¼ú ¹ßÀü(½ÉÀå ¿þ¾î·¯ºí ±â±âÀÇ ÀΰøÁö´É »ç¿ë µî)À¸·Î ÀÎÇØ ½ÉÀåÇÐ ±â±â·Î °ü¸®µÇ´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, Ä¡·á ¹× ¸ð´ÏÅ͸µ °á°ú°¡ ºñ¾àÀûÀ¸·Î Çâ»óµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÇ·á Àü¹®°¡µéÀÌ Áúº´ÀÇ Áø´Ü, ÃßÀû ¹× Ä¡·á¸¦ À§ÇØ Áø´Ü ¼¾ÅÍ¿¡¼ °Ë»ç ¹× Ä¡·á¸¦ ¼öÇàÇϱ⠶§¹®¿¡ Áø´Ü ¼¾ÅÍ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø´Ü ¼¾ÅÍ´Â ´Ù¾çÇÑ ¸ñÀûÀ¸·Î ÀÇ·á±â±â¸¦ »ç¿ëÇÕ´Ï´Ù. Áø´Ü ¼¾ÅÍ´Â ÃÖ÷´Ü ÀÇ·á±â±â¸¦ µµÀÔÇÏ¿© Áø´ÜÀÇ Á¤È®¼º, ¼Óµµ, È¿À²¼ºÀ» ¸ðµÎ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áúº´ÀÇ Á¶±â Áø´Ü, ÃßÀû ¹× ¸ÂÃãÇü Ä¡·á °èȹÀ» Áö¿øÇÕ´Ï´Ù. Áø´Ü¼¾ÅͰ¡ ¾çÁúÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ´É·ÂÀº ºü¸£°Ô º¯ÈÇÏ´Â Áø´Ü ±â¼ú ºÐ¾ß¿¡ ÀÇÇØ Áö¼ÓÀûÀ¸·Î Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì Áö¿ªÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ³ôÀº ÀÇ·á ºñ¿ë, ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÇ·á±â±â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÏ¹Ý Àα¸¿¡¼ ±Þ¼º È£Èí±â ÁõÈıº°ú °°Àº È£Èí±â Áúȯ°ú ½ÉÇ÷°ü Áúȯ, °ü»óµ¿¸Æ ½ÉÀå Áúȯ, ³úÁ¹Áß°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ½ÉÆó ¿ìȸ¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á±â±â ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå È®´ë´Â ±â¾÷µéÀÌ ÃÖ÷´Ü Á¦Ç°À» ¸¸µå´Â µ¥ ÁÖ·ÂÇϰí, ½ÃÀå ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ Á¦ÈÞ ¹× Àμö µî ´Ù¾çÇÑ ºñÁö´Ï½º Àü¼úÀ» äÅÃÇÏ°Ô µÈ °á°úÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸ °í·ÉÈ, 1ÀÎ´ç ¼Òµæ Áõ°¡, ±¹¹ÎµéÀÇ °Ç° ÀÎ½Ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇß½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹°ú Àεµ´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä ±¹°¡ Áß ÇϳªÀ̸ç, °¢°¢ ¼¼°è ½ÃÀå¿¡¼ ¸ÅÃâ 2À§¿Í 5À§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡¿¡¼´Â ÀÇ·á °³Çõ°ú Áö¹æ Á¤ºÎÀÇ Àμ¾Æ¼ºê°¡ ÀÇ·á±â±â »ê¾÷ÀÇ ´ëºÎºÐÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Medical Device Market is accounted for $552.6 billion in 2023 and is expected to reach $941.0 billion by 2030 growing at a CAGR of 7.9% during the forecast period. An equipment, machine, implant, or in vitro reagent designed to be used in the identification, mitigation, monitoring, treatment, or prevention of illness or damage is referred to as a medical device. Medical devices come in a wide range of applications and levels of sophistication, but they are all vital to healthcare since they help with diagnosis and treatment of medical disorders. Manufacturers, retailers, and regulatory agencies all operate internationally in the medical device sector, which is a worldwide business.
According to 2022 statistics published by IDF, about 2.9 million people were living with diabetes in Canada in 2021. In addition, as per the same source, this number is projected to reach 3.2 million and 3.4 million by 2030 and 2045, respectively.
The market for medical devices is significantly impacted by the growing incidence of chronic illnesses. Chronic illnesses frequently call for ongoing care and observation, including diabetes, respiratory conditions, cardiovascular diseases, and some forms of cancer. Additionally, remote patient monitoring technologies have advanced technologically due to the requirement for constant monitoring. Thus, healthcare providers can remotely monitor patients to medical gadgets that include connection characteristics like Bluetooth and internet access.
Expensive medical equipment may put a strain on healthcare finances, especially in systems that receive public funding. Moreover, the cost of purchasing and maintaining sophisticated technology can be prohibitive for hospitals and other healthcare institutions, which has an impact on their entire operating budget. Thus expensive medical equipment may be difficult for smaller healthcare institutions, such outpatient clinics or rural clinics, to afford and this makes it more difficult for them to offer a wide range of services, which might result in gaps in the delivery of healthcare thereby hampering the market growth
There has been a surge in demand for home monitoring equipment, including glucometers, wearable fitness trackers, and blood pressure monitors and with the use of these gadgets, people may keep tabs on and take control of their health issues without constantly visiting medical institutions. Thus technology is always evolving due to the need for at-home medical equipment. To improve the entire patient experience, manufacturers are creating devices with intuitive user interfaces, connection features, and remote monitoring capabilities. Digital thermometers for use at home and telehealth platforms have become popular examples of devices that make remote consultations possible thereby propelling the growth of the market.
Regulatory adjustments are expected to lead to higher costs for patient service offerings and the creation of new products. Among these advances related to secrecy of consumption are the General Data Protection Regulation (GDPR), which was put into effect by the European Union, and modifications to device approvals. The US FDA has asked for more clinical evidence to support the security and efficacy claims of medical equipment, such as endoscopic tools, which has resulted in a decreased extension of the time required to complete the marketing authorization process during the last ten years. The potential for missed revenues due to device release delays and higher costs as a result of onerous regulatory processes put pressure on investments in innovative devices, which affect the growth of the market for medical devices.
The COVID-19 pandemic affected the world market for medical equipment in a variety of ways. The unexpected increase in corona virus diagnoses around the globe has increased demand for medical equipment including respiration devices, ventilators, masks, personal protective equipment kits, and other items. Additionally, the use of digital health technologies like telemedicine and remote patient monitoring has increased dramatically during the COVID-19 epidemic. The market for medical equipment is expanding at a faster rate now. However, all non-essential surgical operations were put on hold during the peak days of COVID-19, giving preference to elective surgical treatments. This had a detrimental impact on the firms who make medical devices for necessary surgical procedures.
The cardiology devices segment is estimated to have a lucrative growth, due to many reasons, including the increasing incidence of cardiovascular illnesses, tactical moves by prominent industry players, and advancements in technology in cardiology devices. Furthermore, since more people with obesity, diabetes, hypertension, and high cholesterol live longer lives and are more prone to experience cardiac issues, these conditions are also driving up demand for cardiological medical equipment. Furthermore, an increasing number of patients are being managed with cardiology devices as a result of expanding business operations and technological advancements (such as the use of artificial intelligence in cardiac wearable devices), which has led to exponential therapeutical and monitoring outcomes are driving the growth of the market.
The diagnostic centers segment is anticipated to witness the highest CAGR growth during the forecast period, as healthcare experts conduct tests and treatments in diagnostic centers in order to diagnose, track, and treat illnesses. Diagnostic facilities employ medical equipment for a variety of purposes. Diagnostic accuracy, speed, and efficiency are all improved in diagnostic centers by the incorporation of cutting-edge medical equipment. Additionally, it supports the early diagnosis, tracking, and customized treatment planning of diseases. Diagnostic centers' capacity to deliver high-quality healthcare services is continually shaped by the rapidly changing field of diagnostic technologies.
North America is projected to hold the largest market share during the forecast period owing to the Over the course of the forecast period, North America is anticipated to lead the medical devices market due to factors including the rising prevalence of chronic illnesses, high healthcare costs, and the presence of major companies. Furthermore, the medical device demand rises as a result of an increase in cardiopulmonary bypass procedures brought on by the rising prevalence of respiratory diseases like acute respiratory syndrome and chronic diseases like cardiovascular disease, coronary heart disease, and stroke in the general population. Thus the market is expanding as a result of businesses' increasing emphasis on creating cutting-edge goods and their adoption of diverse business tactics, such partnerships and acquisitions, to maintain their market positions.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to factors such as an aging population, rising per capita income, and increased health consciousness among the populace, the Asia Pacific area grew at the quickest rate throughout the projected period. Moreover, the rising investments in the region's healthcare infrastructure are expected to support the growth of the medical device market. China and India are two of the major nations in the Asia Pacific area, ranking second and fifth respectively in the world market for revenue. In these nations, healthcare reforms and incentives provided by local governments mostly control the medical device industry.
Some of the key players profiled in the Medical Device Market include: Stryker, Medtronic, Fresenius SE & Co. KGaA, Abbott, Cardinal Health, BD, Koninklijke Philips N.V., General Electric Company, Siemens Healthineers AG, 3M Company, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Smith & Nephew PLC, Braun Melsungen AG, Intuitive Surgical, Fujifilm, Canon Medical Systems, Alcon Laboratories, Edwards Lifesciences and Thermo Fisher
In November 2023, Fresenius Kabi announced the launch of its tocilizumab biosimilar Tyenne® referencing RoActemra®** (tocilizumab) in the European Union. Tyenne® becomes the first tocilizumab biosimilar available in Europe for the treatment of several inflammatory and immune diseases.
In September 2023, Medtronic plc in healthcare technology, announced CE (Conformite Europeenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process.